-
Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
J Immunol. 2009 Mar 15;182(6):3801-8
PMID: 19265159
-
Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
Cancer Res. 2010 Jun 1;70(11):4335-45
PMID: 20484028
-
Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route.
Blood. 1996 Mar 15;87(6):2148-53
PMID: 8630373
-
A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations.
FASEB J. 2006 Sep;20(11):1921-3
PMID: 16877523
-
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.
Cancer Cell. 2011 Apr 12;19(4):441-55
PMID: 21481787
-
Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
J Immunol. 2004 Jun 15;172(12):7335-40
PMID: 15187109
-
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.
Eur J Cancer. 2004 Jul;40(11):1660-7
PMID: 15251154
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43
PMID: 8097319
-
Prevalence of ras gene mutations in human colorectal cancers.
Nature. 1987 May 28-Jun 3;327(6120):293-7
PMID: 3587348
-
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
J Exp Med. 2005 Oct 17;202(8):1075-85
PMID: 16230475
-
Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
J Leukoc Biol. 2011 Feb;89(2):311-7
PMID: 21106641
-
Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
N Engl J Med. 1995 Aug 24;333(8):487-93
PMID: 7542747
-
Myeloid lineage commitment from the hematopoietic stem cell.
Immunity. 2007 Jun;26(6):726-40
PMID: 17582345
-
Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.
Clin Cancer Res. 2008 Dec 15;14(24):8270-8
PMID: 19088044
-
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.
Cancer Res. 2006 Jan 15;66(2):1123-31
PMID: 16424049
-
Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
Stem Cells. 2010 Mar 31;28(3):620-32
PMID: 20073041
-
Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells.
Blood. 1993 Apr 1;81(7):1841-8
PMID: 8461470
-
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Cancer Res. 2007 May 1;67(9):4507-13
PMID: 17483367
-
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
Nat Med. 2012 Aug;18(8):1254-61
PMID: 22842478
-
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
Cancer Res. 2007 Oct 15;67(20):10019-26
PMID: 17942936
-
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.
J Exp Med. 2006 Nov 27;203(12):2691-702
PMID: 17101732
-
Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.
Genes Dev. 1998 Jun 1;12(11):1610-20
PMID: 9620849
-
Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.
Int J Biochem Cell Biol. 2010 Feb;42(2):198-201
PMID: 19788928
-
Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
Prostate. 2010 Mar 1;70(4):443-55
PMID: 19902470
-
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74
PMID: 21376230
-
Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells.
Cancer Immunol Immunother. 2008 Oct;57(10):1493-504
PMID: 18322683
-
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
J Immunol. 2008 Oct 1;181(7):4666-75
PMID: 18802069
-
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.
J Clin Invest. 2010 Feb;120(2):457-71
PMID: 20093776
-
Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.
Cancer Cell. 2008 Nov 4;14(5):408-19
PMID: 18977329
-
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.
Nature. 2000 Sep 21;407(6802):383-6
PMID: 11014194
-
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy.
Cancer Immunol Immunother. 2011 Sep;60(9):1269-79
PMID: 21604071
-
TGF-beta: a mobile purveyor of immune privilege.
Immunol Rev. 2006 Oct;213:213-27
PMID: 16972906
-
The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
Science. 1997 Jul 18;277(5324):333-8
PMID: 9219684
-
Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice.
J Immunol. 2000 Dec 1;165(11):6024-8
PMID: 11086033
-
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Cancer Cell. 2008 Jan;13(1):23-35
PMID: 18167337
-
E2f1-3 are critical for myeloid development.
J Biol Chem. 2011 Feb 11;286(6):4783-95
PMID: 21115501
-
Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny.
Immunity. 2006 Sep;25(3):487-97
PMID: 16949316
-
Activation of phosphoinositide 3-kinase gamma by Ras.
Curr Biol. 2002 Jul 9;12(13):1068-75
PMID: 12121613
-
Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta.
J Endocrinol. 1996 May;149(2):249-58
PMID: 8708536
-
Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism.
PLoS One. 2011;6(11):e27690
PMID: 22110722
-
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
J Immunol Methods. 2012 Jul 31;381(1-2):14-22
PMID: 22522114
-
Subsets of myeloid-derived suppressor cells in tumor-bearing mice.
J Immunol. 2008 Oct 15;181(8):5791-802
PMID: 18832739
-
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.
J Exp Med. 2008 Sep 29;205(10):2235-49
PMID: 18809714
-
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
J Immunol. 2009 May 15;182(10):6562-8
PMID: 19414811
-
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
J Immunol. 2010 Aug 15;185(4):2273-84
PMID: 20644162
-
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.
J Exp Med. 1992 Jul 1;176(1):287-92
PMID: 1613462
-
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
Cancer Res. 2001 Jun 15;61(12):4756-60
PMID: 11406548
-
Myeloid-derived suppressor cells as regulators of the immune system.
Nat Rev Immunol. 2009 Mar;9(3):162-74
PMID: 19197294
-
SOCS3 negatively regulates IL-6 signaling in vivo.
Nat Immunol. 2003 Jun;4(6):540-5
PMID: 12754505
-
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.
Cancer Res. 2011 Dec 15;71(24):7463-70
PMID: 22025564
-
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16078-83
PMID: 16249345
-
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.
J Clin Invest. 2013 Apr;123(4):1580-9
PMID: 23454751
-
Aberrant activation of JAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interferon-gamma in NFS-60 cells.
Growth Factors. 1996;13(3-4):251-60
PMID: 8919032
-
Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains.
J Exp Med. 1990 Dec 1;172(6):1559-70
PMID: 2147944
-
Phosphatidylinositol 3-kinase c2alpha contains a nuclear localization sequence and associates with nuclear speckles.
J Biol Chem. 2001 Dec 21;276(51):48135-42
PMID: 11606566
-
Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248.
J Biol Chem. 2002 Jul 19;277(29):26293-9
PMID: 11978795
-
Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.
Clin Cancer Res. 2008 Oct 15;14(20):6674-82
PMID: 18927310
-
G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood.
Immunity. 2002 Oct;17(4):413-23
PMID: 12387736
-
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.
Nat Immunol. 2013 Mar;14(3):211-20
PMID: 23354483
-
Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1.
Blood. 2004 Feb 1;103(3):1114-23
PMID: 14525772
-
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.
Cell. 2006 Jan 27;124(2):263-6
PMID: 16439202
-
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
Nature. 2000 Mar 9;404(6774):193-7
PMID: 10724173
-
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
Nature. 2009 Dec 17;462(7275):930-4
PMID: 20016602
-
G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells.
Clin Immunol. 2012 Apr;143(1):83-7
PMID: 22341087
-
Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts.
Blood. 1995 Oct 15;86(8):2948-56
PMID: 7579387
-
Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Eur J Immunol. 1998 Jan;28(1):122-33
PMID: 9485192
-
The JAK-STAT pathway at twenty.
Immunity. 2012 Apr 20;36(4):503-14
PMID: 22520844
-
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma.
Clin Cancer Res. 1996 Feb;2(2):295-302
PMID: 9816172
-
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.
Neuro Oncol. 2011 Jun;13(6):591-9
PMID: 21636707
-
Colony stimulating factors and myeloid cell biology in health and disease.
Trends Immunol. 2013 Feb;34(2):81-9
PMID: 23000011
-
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
Clin Cancer Res. 2009 Mar 15;15(6):2148-57
PMID: 19276286
-
A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.
J Clin Invest. 2006 Jul;116(7):2033-43
PMID: 16778989
-
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
Cancer Immunol Immunother. 2009 Jan;58(1):49-59
PMID: 18446337
-
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.
J Immunol. 2006 Nov 15;177(10):7303-11
PMID: 17082649
-
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
J Immunol. 2003 Jan 1;170(1):270-8
PMID: 12496409
-
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
Nat Rev Cancer. 2006 Mar;6(3):184-92
PMID: 16453012
-
Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.
Cell. 2007 Jun 15;129(6):1081-95
PMID: 17574022
-
Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.
Arthritis Rheum. 2011 Aug;63(8):2340-51
PMID: 21809323
-
Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish.
Dev Cell. 2010 Feb 16;18(2):226-36
PMID: 20159593
-
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
J Clin Oncol. 2007 Jun 20;25(18):2546-53
PMID: 17577033
-
Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
J Cancer Res Clin Oncol. 2010 Jan;136(1):35-45
PMID: 19572148
-
The TSC-mTOR signaling pathway regulates the innate inflammatory response.
Immunity. 2008 Oct 17;29(4):565-77
PMID: 18848473
-
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.
Cancer Res. 2011 Aug 1;71(15):5101-10
PMID: 21680779
-
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
Trends Immunol. 2002 Nov;23(11):549-55
PMID: 12401408
-
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
Science. 1994 Jun 3;264(5164):1415-21
PMID: 8197455
-
Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.
Cancer Res. 2012 Mar 15;72(6):1363-72
PMID: 22287548
-
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
J Immunol. 2005 Jan 15;174(2):636-45
PMID: 15634881
-
Macrophage activation and polarization.
Front Biosci. 2008 Jan 01;13:453-61
PMID: 17981560
-
Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death.
J Leukoc Biol. 2006 Dec;80(6):1445-53
PMID: 16973889
-
STAT3 controls myeloid progenitor growth during emergency granulopoiesis.
Blood. 2010 Oct 7;116(14):2462-71
PMID: 20581311
-
Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.
J Immunol. 2009 May 1;182(9):5693-701
PMID: 19380816
-
Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation.
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):2985-8
PMID: 7512720
-
Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
Cancer Res. 1995 Oct 15;55(20):4575-80
PMID: 7553632
-
SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation.
Blood. 2001 Mar 1;97(5):1343-51
PMID: 11222379
-
New roles of Rb1 in expansion of MDSCs in cancer.
Cell Cycle. 2013 May 1;12(9):1329-30
PMID: 23588070
-
Multiple levels of MHC class I down-regulation by ras oncogenes.
Scand J Immunol. 1996 May;43(5):537-44
PMID: 8633212
-
Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis.
Cell Signal. 2003 Feb;15(2):225-33
PMID: 12464394
-
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.
Cancer Res. 2006 Sep 15;66(18):9299-307
PMID: 16982775
-
The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.
Cancer Cell. 2011 Apr 12;19(4):429-31
PMID: 21481782
-
Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment.
Oncoimmunology. 2013 Jul 1;2(7):e24891
PMID: 24073373
-
Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.
Am J Pathol. 2011 Oct;179(4):2131-41
PMID: 21864492
-
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.
Nat Med. 2011 Mar;17(3):320-9
PMID: 21383745
-
IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.
Eur J Immunol. 2010 Dec;40(12):3347-57
PMID: 21110318
-
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.
J Clin Invest. 2013 Oct;123(10):4464-78
PMID: 24091328
-
GM-CSF in inflammation and autoimmunity.
Trends Immunol. 2002 Aug;23(8):403-8
PMID: 12133803
-
Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.
Cancer Res. 2009 Mar 15;69(6):2506-13
PMID: 19244102
-
Granulocyte colony-stimulating factor and its receptor.
Blood. 1991 Dec 1;78(11):2791-808
PMID: 1720034
-
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions.
Circulation. 2012 Jan 17;125(2):364-74
PMID: 22144566
-
Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
J Immunol. 1996 Mar 1;156(5):1916-22
PMID: 8596044
-
Rapamycin and mTOR kinase inhibitors.
J Chem Biol. 2008 Nov;1(1-4):27-36
PMID: 19568796
-
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.
J Exp Med. 2003 Dec 1;198(11):1741-52
PMID: 14657224
-
[Myeloid-derived suppressor cells: a key player in cancer].
Med Sci (Paris). 2010 Jun-Jul;26(6-7):576-9
PMID: 20619155
-
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.
Cancer Res. 2005 Apr 15;65(8):3044-8
PMID: 15833831
-
Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function.
Cancer Sci. 2003 Sep;94(9):814-20
PMID: 12967481
-
Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
Clin Cancer Res. 1995 Jan;1(1):95-103
PMID: 9815891
-
S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
Immunology. 2012 Jun;136(2):176-83
PMID: 22304731
-
A novel strategy for modulation of MDSC to enhance cancer immunotherapy.
Oncoimmunology. 2012 Sep 1;1(6):984-985
PMID: 23162780
-
SHIP represses the generation of alternatively activated macrophages.
Immunity. 2005 Oct;23(4):361-74
PMID: 16226502
-
MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
J Immunol. 2012 Jun 1;188(11):5500-10
PMID: 22544933
-
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
Cancer Res. 2009 Feb 15;69(4):1553-60
PMID: 19201693
-
The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.
Cell. 2008 Aug 8;134(3):496-507
PMID: 18692472
-
Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.
J Immunol. 2003 Feb 15;170(4):2014-21
PMID: 12574371
-
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
J Biol Chem. 2005 Sep 23;280(38):33076-82
PMID: 16049009
-
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.
Cancer Res. 2004 Sep 1;64(17):6337-43
PMID: 15342423
-
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
J Cancer Ther. 2013 May;4(3):797-803
PMID: 24089656
-
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
Science. 2002 Aug 9;297(5583):1031-4
PMID: 12130661
-
The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
Cell. 1985 Jul;41(3):665-76
PMID: 2408759
-
Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
Cancer Res. 2007 Oct 1;67(19):9518-27
PMID: 17909062
-
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.
J Exp Med. 2005 Oct 3;202(7):931-9
PMID: 16186186
-
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.
J Immunol. 2001 Jan 1;166(1):678-89
PMID: 11123353
-
CSF-1--a mononuclear phagocyte lineage-specific hemopoietic growth factor.
J Cell Biochem. 1983;21(2):151-9
PMID: 6309875
-
Regulation of granulocyte apoptosis by phosphatidylinositol 3-kinase.
Biochem Soc Trans. 2004 Jun;32(Pt3):480-4
PMID: 15157166
-
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.
Cancer Cell. 2011 Apr 12;19(4):456-69
PMID: 21481788
-
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
Blood. 2010 Feb 18;115(7):1461-71
PMID: 20008303
-
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
J Leukoc Biol. 2012 Nov;92(5):987-97
PMID: 22891289
-
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.
Nat Immunol. 2010 Oct;11(10):889-96
PMID: 20856220
-
Distinct signatures of the immune responses in low risk versus high risk neuroblastoma.
J Transl Med. 2011 Oct 06;9:170
PMID: 21978632
-
A role for immature myeloid cells in immune senescence.
J Immunol. 2011 Jan 15;186(2):697-707
PMID: 21148798
-
Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.
Science. 2000 Feb 11;287(5455):1049-53
PMID: 10669418
-
ras genes.
Annu Rev Biochem. 1987;56:779-827
PMID: 3304147
-
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
Clin Cancer Res. 2008 Sep 15;14(18):5884-92
PMID: 18794101
-
Monocyte and macrophage heterogeneity.
Nat Rev Immunol. 2005 Dec;5(12):953-64
PMID: 16322748
-
Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family.
Cell Stem Cell. 2008 Oct 9;3(4):416-28
PMID: 18940733
-
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.
J Leukoc Biol. 2010 Nov;88(5):839-48
PMID: 20587738
-
Induction of myeloid-derived suppressor cells by tumor exosomes.
Int J Cancer. 2009 Jun 1;124(11):2621-33
PMID: 19235923
-
Delayed hematopoietic development in osteopetrotic (op/op) mice.
J Exp Med. 1993 Jan 1;177(1):237-42
PMID: 8418205
-
G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
Nat Med. 2005 Mar;11(3):305-11
PMID: 15723072
-
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
Gastroenterology. 2008 Jul;135(1):234-43
PMID: 18485901
-
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.
J Clin Invest. 2008 Oct;118(10):3367-77
PMID: 18776941
-
Deactivation of macrophages by transforming growth factor-beta.
Nature. 1988 Jul 21;334(6179):260-2
PMID: 3041283
-
The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs.
Eur J Immunol. 1997 Jan;27(1):40-4
PMID: 9021996
-
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.
Nat Rev Genet. 2006 Aug;7(8):606-19
PMID: 16847462
-
Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
J Immunol. 2009 Jan 1;182(1):240-9
PMID: 19109155
-
Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
J Immunol. 1998 Nov 15;161(10):5382-90
PMID: 9820512
-
Suppressors of cytokine signalling (SOCS) in the immune system.
Nat Rev Immunol. 2002 Jun;2(6):410-6
PMID: 12093007
-
Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.
Cancer Cell. 2011 Jan 18;19(1):72-85
PMID: 21251614